Pharmafile Logo

Bedrock are in the Top 3

Bedrock named No. 3 Young Agency by PMLive

- PMLiVE

Bedrock has been named as the No. 3 Young Agency by PMLive and ranked No. 6 in the Top 10 Independent Agencies who had the most impact in the UK healthcare sector in 2018.

“This is a great result for Bedrock,” says Alison Cantle, Managing Director. “It reflects the creative approach on which we have built our reputation and confirms our place in the sweet spot that demands impactful data storytelling for our pharma clients.”

The rankings are calculated from several factors using data supplied by the agencies supplemented with addition information in the public domain. Full details of the data sources and the methodology used to produce this year’s list are available here.

Bedrock marries robust scientific knowledge with outstanding creative thinking. In collaboration with our clients, we use our deep understanding of behaviour change and patient engagement to imagine, create and deliver impactful programmes that will inform, educate and inspire clinicians. Our teams can harness and transform raw data into impactful and memorable visual information pieces that are disseminated to wide ranging audiences.

“We work with everyone from small biotechs, particularly in rare diseases, to large pharmaceutical organisations, where we support strategy and tactical delivery of educational materials for product launch and lifecycle management,” added Alison.

For an informal chat with our Managing Director, Alison Cantle, or to organise an introductory strategic workshop to highlight how Bedrock might add value, support brand planning and help meet strategic imperatives, please call her directly on +44(0)1252 240237.

- PMLiVE

Alison Cantle, Managing Director, Bedrock

Or if you prefer to read more about Bedrock, visit www.bedrock-health.com

This content was provided by Bedrock Healthcare Communications

Company Details

 Latest Content from  Bedrock Healthcare Communications 

Why we need to look at rare diseases in a different way

28 February 2021, Rare Disease Day aims to raise awareness of rare diseases and the impact they have on patients’ lives.

The Unknown Unknowns

Patient insights are fundamental to ensuring we understand the reality of living with a condition. We need to consciously  challenge our approach and ensure we are unearthing authentic patient insights that...

Do you know what PoTS is?

As part of Dysautonomia Awareness Month, Origins continues its efforts in raising awareness and understanding of Postural Tachycardia Syndrome (PoTS), a Dysautonomia condition affecting young women that can be very...

Leadership change within Bedrock Group

Marie Little appointed Managing Director of Bedrock Healthcare Communications Limited

Origins Insights: views from the team

First in a video series from the Origins Insights team discussing some of our views, experiences, values and opinions across many aspects of qualitative patient research activities.

Bedrock Group strengthens its senior team

Bedrock Healthcare Communications have strengthened its senior management team

PoTS LIVE: A unique ethnography study in rare disease

Digital ethnography has been deployed with PoTS patients for the first time, by Origins Insights, with significant results for the PoTS UK charity.

Intelligence that redefines success

It's true, you can't judge a book by its cover. Digital ethnography uncovers deep, impactful patient insights that can transform thinking and redefine your success.

Origins Insights: Intelligence that redefines success

Origins Insights delivers deep insight and intelligence that can transform thinking and redefine your success.

Bedrock double up

Bedrock selected as a finalist in two categories for 2020 Communiqué awards